InsidersTradesSigma
Explore the complete record of transactions filed by Sinclair Michael, Director. Insider active across 1 companies, notably Opiant Pharmaceuticals, INC.. Aggregated, 6 disclosures have been recorded. Total volume traded: €368k. The latest transaction was disclosed on 13 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
6 of 6 declarations
Michael Sinclair is a Board Member of Opiant Pharmaceuticals, Inc. As a board member, he participates in strategic decision-making and oversight of the company's operations. Sinclair brings valuable expertise in the pharmaceutical sector, helping to guide direction and ensure compliance with regulations. His role is essential in ensuring good governance at Opiant Pharmaceuticals.